RK-013
N/A
Report date: 2025/04/07 12:00:18
Base Information
Drug NameRK-013
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRevolKa Ltd
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A